Protocol for Evaluation of eLearning of Quality Improvement Methods

Status Completed

Clinical Trial Summary

This study evaluates the use of eLearning of quality improvement methods. Participants who use eLearning only, facilitated learning only and a combination of eLearning and facilitated learning will complete questionnaires and be interviewed to establish the effect of eLearning of quality improvement methods to improve knowledge, change in behaviour and impact on healthcare services for better patient care.

Clinical Trial Description

Quality improvement (QI) is an increasingly important element of delivering health care. Learning and feeling confident in using QI methods is an essential part of healthcare practice. eLearning is a cost effective way of capacity building to a large cohort of health care professionals and service users. National Institute of Health Research Collaboration for Leadership in Health Research and Care Northwest London has developed a suite of eLearning modules (QI4U) to support an introductory understanding of technical aspects of QI. This protocol describes a trial to evaluate the experience of learning, knowledge gained, change in behaviour, and impact of eLearning of QI methods.

Participants will belong to one of three Groups of learners over the course of 12 months: learners using only QI4U (group 1); people using only facilitated learning (Group 2); and learners using a combination of QI4U and facilitated learning (Group 3). The Kirkpatrick model will be used to evaluate the learning. The primary outcome of interest will be transfer of knowledge gained from learning into clinical practice for service improvement by individuals (level 3). Secondary outcomes will include reaction or experience of QI4U, knowledge gained, and the results or impact of learning through QI4U on service improvement (levels 1, 2 and 4).

Transfer of knowledge into clinical practice will be assessed by interviews with individual learners. Experience of eLearning and knowledge gained will be assessed using feedback forms, questionnaires, time spent doing QI4U and reflective logs. Impact will be assessed by interviews with organisational leads with a high prevalence of QI4U learners.

This study will provide evidence on the effectiveness of using eLearning as a means for learning QI. It will serve to evaluate learners' experience of using eLearning and the impact of various training methods within the context of learning QI. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02907541
Study type	Interventional
Source	Chelsea and Westminster NHS Foundation Trust
Contact
Status	Completed
Phase	N/A
Start date	January 2017
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05817253` - Evaluation of Therapeutic Initiative's Cystitis Portrait and Therapeutics Letter	N/A
Not yet recruiting	`NCT03793946` - A Digital Antimicrobial Stewardship Smartphone Application to Combat AMR: the AB-assistant	N/A
Completed	`NCT02922101` - Evaluation of the Effectiveness of an Audit and Feedback Intervention With Quality Improvement Toolbox in Intensive Care	N/A
Completed	`NCT01931553` - A Pragmatic Cluster Randomized Controlled Trial to Standardize Attending Morning Rounds in Medicine	N/A
Completed	`NCT04037787` - ERAS (Enhanced Recovery After Surgery) Protocol Implementation in Piedmont Region for Colorectal Cancer Surgery	N/A
Recruiting	`NCT05050266` - Enhancing Mental and Physical Health of Women Veterans	N/A
Recruiting	`NCT06085690` - Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science	N/A
Completed	`NCT05794490` - Learning From Excellence in a Hospital Unit
Active, not recruiting	`NCT03724695` - Advanced Heart Care at Home	N/A
Recruiting	`NCT04383379` - To Improve the Rate of Mother's Own Milk Feeding of Premature Infants in NICU	N/A
Not yet recruiting	`NCT05852080` - Multilevel System Intervention Based on Information Platform to Reduce Ischemic Stroke Recurrence Rate	N/A
Enrolling by invitation	`NCT03689049` - SPIDER: A Research & QI Collaboration Supporting Practices in Improving Care for Complex Elderly Patients	N/A
Enrolling by invitation	`NCT05133700` - Use and Opinions of Care Home Medicines Audit Tools
Completed	`NCT02882594` - Testing the Reliability and Validity of the CIBA	N/A
Completed	`NCT00134823` - Improving Pediatric Safety and Quality With Health Care Information Technology	N/A
Completed	`NCT03824990` - Multi-center Clinical Study on Neonatal Hyperbilirubinemia	N/A
Completed	`NCT03775551` - Counter-referral System Improvement Collaborative	N/A
Recruiting	`NCT04886427` - Implementation of a Multidimensional Quality Model
Withdrawn	`NCT03210116` - Quality Improvement in Palliative Care Consultation in a Medical ICU	N/A
Completed	`NCT03000751` - CT DOSE Collaboratory	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.